# Sirtex Medical agrees to $1.43bn acquisition by CDH and CGP

Australian medical device firm Sirtex Medical agreed to a binding scheme implementation deed for A$1.9bn ($1.43bn) acquisition proposal from CDH Genetech and China Grand Pharmaceutical and Healthcare (CGP). The deal is at A$33.6 per share, higher than a previous offer from Varian.

- Type: Acquisition
- Announced: 2018-06-15
- Where: Australia
- Value: $1.43B
- Status: announced
- Products: medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [China Grand Pharmaceutical and Healthcare](https://endata.com/companies/28136.md) (acquirer)
- [Sirtex Medical](https://endata.com/companies/29756.md) (target)
- [CDH Genetech](https://endata.com/companies/32599.md) (acquirer)

## Sources

- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/sirtex-agrees-1-4bn-acquisition-chinas-cdh/), 2018-06-14: "Australian medical device firm Sirtex Medical has agreed to a binding scheme implementation deed for A$1.9bn ($1.43bn) acquisition proposal from Chinese company CDH Genetech and its strategic partner China Grand Pharmaceutical and Healthcare (CGP)."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.